e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Clinical issues in idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Retrospective study on the treatment and prognosis of acute exacerbation of idiopathic pulmonary fibrosis in Japan
T. Hajiro, M. Ebina, M. Suga, Y. Inoue, H. Taniguchi, T. Nukiwa, Y. Taguchi, DLD Research Group in Japan (Nara, Miyagi, Kumamoto, Osaka, Aichi, Japan)
Source:
Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Session:
Clinical issues in idiopathic pulmonary fibrosis
Session type:
Oral Presentation
Number:
3630
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hajiro, M. Ebina, M. Suga, Y. Inoue, H. Taniguchi, T. Nukiwa, Y. Taguchi, DLD Research Group in Japan (Nara, Miyagi, Kumamoto, Osaka, Aichi, Japan). Retrospective study on the treatment and prognosis of acute exacerbation of idiopathic pulmonary fibrosis in Japan. Eur Respir J 2010; 36: Suppl. 54, 3630
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Diagnosis and therapy of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) in Germany
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in Japan
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020
Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Retrospective analysis of characteristics and costs of hospital treatment of chronic obstructive pulmonary disease exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016
Prospective study of infectious bacterial etiology of acute exacerbation of chronic obstructive pulmonary disease in India
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment II
Year: 2016
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept